Details for New Drug Application (NDA): 215379
✉ Email this page to a colleague
The generic ingredient in LACOSAMIDE is lacosamide. There are twenty-two drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the lacosamide profile page.
Summary for 215379
Tradename: | LACOSAMIDE |
Applicant: | Msn |
Ingredient: | lacosamide |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 215379
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 215379
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LACOSAMIDE | lacosamide | SOLUTION;ORAL | 215379 | ANDA | Novadoz Pharmaceuticals LLC | 72205-034 | 72205-034-74 | 200 mL in 1 BOTTLE, PLASTIC (72205-034-74) |
LACOSAMIDE | lacosamide | SOLUTION;ORAL | 215379 | ANDA | Novadoz Pharmaceuticals LLC | 72205-034 | 72205-034-75 | 465 mL in 1 BOTTLE, PLASTIC (72205-034-75) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;ORAL | Strength | 10MG/ML | ||||
Approval Date: | Dec 22, 2023 | TE: | AA | RLD: | No |
Complete Access Available with Subscription